FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2782962010> ?p ?o ?g. }

• W2782962010 endingPage "69" @default.
• W2782962010 startingPage "61" @default.
• W2782962010 abstract "Prostate cancer is the second most common malignancy affecting men worldwide, and the commonest affecting men of African descent. Significant diagnostic and therapeutic advances have been made in the past decade. Improvements in the accuracy of prostate cancer diagnosis include the uptake of multi-parametric MRI and a shift towards targeted biopsy. We also now have more life-prolonging systemic and hormonal therapies for men with advanced disease at our disposal than ever before. However, the development of robust screening tools and targeted screening programs has not followed at the same pace. Evidence to support population-based screening remains unclear, with the use of PSA as a screening test limiting our ability to discriminate between clinically significant and insignificant disease. Prostate cancer has a large heritable component. Given that most men without risk factors have a low lifetime risk of developing lethal prostate cancer, much work is being done to further our knowledge of how we can best screen men in higher risk categories, such as those with a family history (FH) of the disease or those of African ancestry. These men have been reported to carry upwards of a two-fold increased risk of developing the disease at an earlier age, with evidence suggesting poorer survival outcomes. In men with a FH of prostate cancer, this is felt to be due to rare, high-penetrance mutations and the presence of multiple, common low penetrance alleles, with men carrying specific germline mutations in the BRCA and other DNA repair genes at particularly high risk. To date, large scale genome-wide association studies (GWAS) have led to the discovery of approximately 170 single nucleotide polymorphisms (SNPs) associated with prostate cancer risk, allowing over 30% of prostate cancer risk to be explained. Genomic tests, utilising somatic (prostate biopsy) tissue can also predict the risk of unfavourable pathology, biochemical recurrence and the likelihood of metastatic disease using gene expression. Targeted screening studies are currently under way in men with DNA repair mutations, men with a FH and those of Afro-Caribbean ethnicity which will greater inform our understanding of disease incidence and behaviour in these men, treatment outcomes and developing the most appropriate screening regime for such men. Incorporating a patient’s genetic mutation status into risk algorithms allows us an opportunity to develop targeted screening programs for men in whom early cancer detection and treatment will positively influence survival, and in the process offer male family members of affected men the chance to be counselled and screened accordingly." @default.
• W2782962010 created "2018-01-26" @default.
• W2782962010 creator A5011222815 @default.
• W2782962010 creator A5070461302 @default.
• W2782962010 date "2018-02-01" @default.
• W2782962010 modified "2023-10-16" @default.
• W2782962010 title "Men with a susceptibility to prostate cancer and the role of genetic based screening" @default.
• W2782962010 cites W1501381780 @default.
• W2782962010 cites W1508662657 @default.
• W2782962010 cites W1578291413 @default.
• W2782962010 cites W1757407923 @default.
• W2782962010 cites W1901381303 @default.
• W2782962010 cites W1967705369 @default.
• W2782962010 cites W1974326568 @default.
• W2782962010 cites W1977546001 @default.
• W2782962010 cites W1979957847 @default.
• W2782962010 cites W1991778413 @default.
• W2782962010 cites W2004429375 @default.
• W2782962010 cites W2009454156 @default.
• W2782962010 cites W2013426357 @default.
• W2782962010 cites W2016639151 @default.
• W2782962010 cites W2047691299 @default.
• W2782962010 cites W2055482396 @default.
• W2782962010 cites W2066778514 @default.
• W2782962010 cites W2067339842 @default.
• W2782962010 cites W2074220607 @default.
• W2782962010 cites W2076351163 @default.
• W2782962010 cites W2076668528 @default.
• W2782962010 cites W2089333635 @default.
• W2782962010 cites W2091275493 @default.
• W2782962010 cites W2095658137 @default.
• W2782962010 cites W2103263363 @default.
• W2782962010 cites W2110569728 @default.
• W2782962010 cites W2110898286 @default.
• W2782962010 cites W2111659024 @default.
• W2782962010 cites W2116284235 @default.
• W2782962010 cites W2126668914 @default.
• W2782962010 cites W2129800178 @default.
• W2782962010 cites W2134793522 @default.
• W2782962010 cites W2135456872 @default.
• W2782962010 cites W2145657085 @default.
• W2782962010 cites W2160475700 @default.
• W2782962010 cites W2170958906 @default.
• W2782962010 cites W2178232667 @default.
• W2782962010 cites W2235405584 @default.
• W2782962010 cites W2235954515 @default.
• W2782962010 cites W2345972868 @default.
• W2782962010 cites W2414497667 @default.
• W2782962010 cites W2460887855 @default.
• W2782962010 cites W2462985846 @default.
• W2782962010 cites W2523396458 @default.
• W2782962010 cites W2587831721 @default.
• W2782962010 cites W2604768144 @default.
• W2782962010 cites W2741363425 @default.
• W2782962010 cites W2767883250 @default.
• W2782962010 cites W4230373391 @default.
• W2782962010 cites W4232200293 @default.
• W2782962010 cites W588539914 @default.
• W2782962010 cites W143765300 @default.
• W2782962010 doi "https://doi.org/10.21037/tau.2017.12.30" @default.
• W2782962010 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5861282" @default.
• W2782962010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29594021" @default.
• W2782962010 hasPublicationYear "2018" @default.
• W2782962010 type Work @default.
• W2782962010 sameAs 2782962010 @default.
• W2782962010 citedByCount "18" @default.
• W2782962010 countsByYear W27829620102018 @default.
• W2782962010 countsByYear W27829620102019 @default.
• W2782962010 countsByYear W27829620102020 @default.
• W2782962010 countsByYear W27829620102021 @default.
• W2782962010 countsByYear W27829620102022 @default.
• W2782962010 crossrefType "journal-article" @default.
• W2782962010 hasAuthorship W2782962010A5011222815 @default.
• W2782962010 hasAuthorship W2782962010A5070461302 @default.
• W2782962010 hasBestOaLocation W27829620102 @default.
• W2782962010 hasConcept C104317684 @default.
• W2782962010 hasConcept C121608353 @default.
• W2782962010 hasConcept C126322002 @default.
• W2782962010 hasConcept C127716648 @default.
• W2782962010 hasConcept C13514818 @default.
• W2782962010 hasConcept C143998085 @default.
• W2782962010 hasConcept C200544954 @default.
• W2782962010 hasConcept C2775941076 @default.
• W2782962010 hasConcept C2776235491 @default.
• W2782962010 hasConcept C2779134260 @default.
• W2782962010 hasConcept C2779377019 @default.
• W2782962010 hasConcept C2779399171 @default.
• W2782962010 hasConcept C2780192828 @default.
• W2782962010 hasConcept C2780673598 @default.
• W2782962010 hasConcept C2781179581 @default.
• W2782962010 hasConcept C2781406297 @default.
• W2782962010 hasConcept C2908647359 @default.
• W2782962010 hasConcept C501734568 @default.
• W2782962010 hasConcept C54355233 @default.
• W2782962010 hasConcept C71924100 @default.
• W2782962010 hasConcept C86803240 @default.
• W2782962010 hasConcept C99454951 @default.
• W2782962010 hasConceptScore W2782962010C104317684 @default.

• next